The regulatory mechanism of neuromedin S on luteinizing hormone in pigs.
Neuromedin S (NMS) has been implicated in the regulation of luteinizing hormone (LH) secretion. However, the regulatory mechanism of NMS on LH in pigs remains unexplored. In the present study, we confirmed the hypothesis that the effect of NMS on LH could be mediated via hypothalamic melanocyte-stimulating hormones (MSH) neurons of ovariectomized pigs. In an immunohistological experiment, NMS receptor NMU2R-positive neurons were found in the paraventricular nucleus of hypothalamus, widely distributed in the anterior pituitary, and sparsely observed in the posterior pituitary. We also found that serum LH level was declined at between 12 and 60 min with the lowest level at 24 min after NMS injection. The decreased LH secretion induced by NMS could be completely abolished by pretreatment with melanocortin receptor-4 antagonist SHU9119, while a signal injection of 1.0 nM SHU9119 per se did not affect the serum LH level. Real time quantitative RT-PCR results showed that the expression of GnRH and LH mRNAs were down-regulated by NMS treatment, but their reduction was restored to normal level by SHU9119 treatments. The expression of NMU2R and PR mRNAs were up-regulated by NMS treatment, but their effects were blocked by SHU9119 treatments. The expression of the estrogen receptor mRNA in the pig hypothalamus and pituitary was unchanged under the NMS and SHU9119+NMS treatments. In summary, all results suggest that the inhibitory effect of NMS on LH is at least in part through its receptor NMU2R and mediated via MSH neurons in hypothalamus-pituitary axis of ovariectomized pigs.
Key Laboratory of Animal Physiology and Biochemistry of Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, Jiangsu, PR China.
Guihong
G
Yang
Juan
J
Su
Yuan
Y
Yao
Zhihai
Z
Lei
Guorui
G
Zhang
Xun
X
Li
D000818:Animals; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D007987:Gonadotropin-Releasing Hormone / Q000235:genetics; D007031:Hypothalamus / Q000737:chemistry / Q000166:cytology; D007700:Kinetics; D007986:Luteinizing Hormone / Q000097:blood / Q000235:genetics / Q000378:metabolism*; D009074:Melanocyte-Stimulating Hormones / Q000032:analysis / Q000494:pharmacology; D009474:Neurons / Q000737:chemistry / Q000502:physiology; D009479:Neuropeptides / Q000008:administration & dosage / Q000502:physiology*; D010052:Ovariectomy; D010902:Pituitary Gland / Q000737:chemistry / Q000166:cytology; D012333:RNA, Messenger / Q000032:analysis; D044105:Receptor, Melanocortin, Type 4 / Q000037:antagonists & inhibitors; D017981:Receptors, Neurotransmitter / Q000032:analysis / Q000235:genetics; D013552:Swine / Q000502:physiology*
D009479:Neuropeptides; D012333:RNA, Messenger; D044105:Receptor, Melanocortin, Type 4; D017981:Receptors, Neurotransmitter; C497950:neuromedin S; C103272:SHU 9119; D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone; D009074:Melanocyte-Stimulating Hormones